Dynavax to Present at the 2015 RBC Capital Markets'' Global Healthcare Conference
(firmenpresse) - BERKELEY, CA -- (Marketwired) -- 02/19/15 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Eddie Grey, the Company''s Chief Executive Officer, will present at the 2015 RBC Capital Markets'' Global Healthcare Conference on Tuesday, February 24, 2015 at 9:30 AM Eastern Time at the New York Palace Hotel in New York City.
A live webcast of the presentation will be available by visiting the "Investors" section of the Dynavax website or may be reached directly at: .
Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax''s lead product candidate is HEPLISAV-B, a Phase 3 investigational adult hepatitis B vaccine. For more information visit .
Michael Ostrach
Chief Business and Principal Financial Officer
510-665-7257
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.02.2015 - 15:15 Uhr
Sprache: Deutsch
News-ID 1338644
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
BERKELEY, CA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 108 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dynavax to Present at the 2015 RBC Capital Markets'' Global Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Dynavax Technologies (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
